单髁膝关节置换术后感染:后续并发症风险高
该回顾性研究纳入1992年至2014年间15例单髁膝关节置换术后假体周围感染患者,评估无再感染生存率、无翻修生存率及膝关节协会评分。5年无感染生存率为71%,两阶段翻修组100%高于清创保留假体组61%;5年无任何翻修生存率为49%。
要点
- 单髁膝关节置换术后假体周围感染5年无感染生存率为71%(95%CI 46%-96%)。
- 两阶段翻修组5年无感染生存率100%,高于清创保留假体组的61%。
- 5年无任何翻修生存率仅49%(95%CI 19%-79%)。
核心结论
- 清创保留假体治疗单髁膝关节置换术后假体周围感染的5年无感染生存率低于两阶段翻修并转为全膝关节置换。
- 单髁膝关节置换术后假体周围感染导致显著病残,除感染复发外还应密切随访无菌性失败原因。
研究设计与样本
- 回顾性研究,数据来自纵向维护的机构登记系统,1992年至2014年间识别15例单髁膝关节置换术后假体周围感染。
- 感染诊断时中位年龄58岁(范围41-82岁),15例中9例为男性,中位体质指数29 kg/m²(范围23-36 kg/m²)。
- 15例中10例满足肌肉骨骼感染学会主要诊断标准;早期术后感染、急性血源性感染和慢性感染各5例。
- 4例接受两阶段翻修,11例接受清创、抗生素和假体保留(DAIR)。
- 13例随访至少2年并纳入临床分析,中位随访4年(范围2-6年)。
主要发现
- 5年无感染生存率为71%(95%CI 46%-96%)。
- 两阶段翻修组5年无感染生存率为100%(95%CI 100%-100%),DAIR组为61%(95%CI 31%-92%)。
- DAIR组11例中4例在末次随访时出现再感染。
- 5年无任何翻修生存率为49%(95%CI 19%-79%)。
- 两阶段翻修组1例因无菌性松动在感染治疗后5年接受股骨假体翻修,DAIR组2例因疾病进展在中位4年时转为全膝关节置换。
关键数值与推荐
- 15例中10例满足肌肉骨骼感染学会主要诊断标准。
- 5年无感染生存率71%(95%CI 46%-96%),两阶段翻修组100%(95%CI 100%-100%)vs DAIR组61%(95%CI 31%-92%)。
- 5年无任何翻修生存率49%(95%CI 19%-79%)。
- 膝关节协会评分中位数从73改善至94(p=0.016)。
临床怎么用
- 作者认为,与两阶段翻修并转为全膝关节置换相比,DAIR治疗单髁膝关节置换术后假体周围感染与较低的5年无感染生存率相关。
- 作者认为,单髁膝关节置换术后假体周围感染导致显著病残,除感染复发外还应密切随访无菌性失败原因。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unicompartmental knee arthroplasty restores function and improves pain in appropriately selected patients. Scant evidence exists regarding the treatment of periprosthetic joint infection (PJI) after unicompartmental knee arthroplasty (UKA). QUESTIONS/PURPOSES: (1) What was the overall survivorship free from reinfection? (2) What is the survivorship free of all-cause revision? (3) What are the Knee Society scores (KSS) and complications after surgical treatment of UKA PJI? METHODS: This retrospective study with data drawn from a longitudinally maintained institutional registry identified 15 UKA PJIs between 1992 and 2014. The median age at PJI diagnosis was 58 years (range, 41-82 years), nine of 15 were men, and the median body mass index was 29 kg/m (range, 23-36 kg/m). Ten patients (10 of 15) satisfied major Musculoskeletal Infection Society diagnostic criteria. There were five patients (five of 15) with early postoperative infections, five (five of 15) with acute hematogenous infections, and five (five of 15) with chronic PJIs. Two-stage exchange was performed in four patients with PJIs (four of 15), and débridement, antibiotics, and implant retention (DAIR) was performed in 11 patients (11 of 15) with PJIs. We performed Kaplan-Meier survivorship analysis for reinfection and revision procedures. Thirteen patients had a minimum of 2 years' followup and were included in the clinical analysis. Median followup was 4 years (range, 2-6 years). We calculated KSS. RESULTS: Infection-free survivorship was 71% at 5 years (95% confidence interval [CI], 46%-96%). Treatment success was higher for patients undergoing two-stage exchange (100% at 5 years; 95% CI, 100%-100%) versus DAIR (61% at 5 years; 95% CI, 31%-92%). Four of 11 patients undergoing DAIR had developed a reinfection at final followup. Survivorship free of any revision was 49% at 5 years (95% CI, 19%-79%). One patient from the two-stage exchange cohort underwent femoral component revision for aseptic loosening 5 years after PJI treatment, and two patients from the DAIR group were converted to TKA for disease progression at a mean of 4 years. In patients with a minimum of 2 years' followup, median KSS improved from 73 (range, 50-93) before index UKA to 94 (range, 55-100; p = 0.016). CONCLUSIONS: Treatment of UKA PJI with DAIR was associated with a lower infection-free survivorship at 5 years compared with two-stage exchange with conversion to TKA. Among those patients who were infection-free, a number needed reoperations for disease progression (in the DAIR group) or component loosening (in both groups). UKA PJI results in substantial morbidity, and patients with these infections should be followed closely for aseptic causes of failure in addition to infection recurrence. LEVEL OF EVIDENCE: Level IV, therapeutic study.
引用
- Hernandez NM, Petis SM, Hanssen AD, et al. Infection After Unicompartmental Knee Arthroplasty: A High Risk of Subsequent Complications. Clin Orthop Relat Res. 2019. PMID: 30794230. doi:10.1097/CORR.0000000000000372
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。